PT-141 – Vital Flow HRT
Skip to content Skip to sidebar Skip to footer

PT-141, also known as Bremelanotide, is a synthetic peptide that has gained popularity as a treatment for sexual dysfunction in both men and women. Here are some lists of important facts about PT-141:

Benefits of PT-141:

Improves sexual desire: PT-141 is primarily used to treat sexual dysfunction, particularly in women with hypoactive sexual desire disorder (HSDD) and men with erectile dysfunction (ED). It stimulates the production of melanocortin, which is a hormone responsible for increasing sexual arousal.

Enhances sexual performance: PT-141 also helps improve sexual performance in both men and women by increasing blood flow to the genital area, which leads to better erections and more intense orgasms.

Improves mood: PT-141 has been shown to improve mood in both men and women, which can lead to the better overall quality of life.

May help with other conditions: PT-141 has been shown to have potential therapeutic benefits for other conditions, such as obesity, sleep disorders, and even traumatic brain injury.

Side effects of PT-141:

Nausea: One of the most common side effects of PT-141 is nausea, which can be mild to severe in some cases.

Headaches: Headaches are another common side effect of PT-141, which may be accompanied by other symptoms like dizziness and fatigue.

Flushing: PT-141 may cause flushing or redness of the skin, particularly on the face and neck.

High blood pressure: In some cases, PT-141 may cause a temporary increase in blood pressure, which can be a concern for individuals with hypertension.

Dosage and administration of PT-141:

Dosage: The recommended dose of PT-141 varies depending on the individual and the condition being treated. For HSDD in women, a starting dose of 1.75mg is recommended, while for ED in men, a starting dose of 1.25mg is recommended.

Administration: PT-141 is typically administered as a subcutaneous injection, which involves injecting the drug under the skin using a small needle. It should be administered approximately 45 minutes before sexual activity.

Frequency: PT-141 should not be used more than once every 24 hours, as this can increase the risk of side effects.

Duration: The effects of PT-141 typically last for several hours, but this can vary depending on the individual and the dose administered.

PT-141 is a promising treatment option for individuals with sexual dysfunction, but it should only be used under the supervision of a healthcare provider. It is important to discuss the potential benefits and risks of PT-141 with a healthcare provider before starting treatment.